U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT06960694) titled 'Effect of L-carnitine on Disease Activity in Patients With Mild to Moderate Knee Osteoarthritis' on April 29.
Brief Summary: The purpose of this study is to evaluate the effects of L-carnitine on symptomatic improvement, oxidative stress, and inflammation in mild to moderate knee osteoarthritis patients.
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Knee Osteoarthritis
Intervention:
DRUG: L-carnitine
This group will be treated with tablet L-carnitine 330 mg 3 times daily for 8 weeks and Naproxen 500 mg twice daily for the first 14 days
DRUG: Placebo
This group will be treated with tablet Placebo 330 mg 3 t...